Profile data is unavailable for this security.
About the company
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.
- Revenue in USD (TTM)224.95bn
- Net income in USD-980.00m
- Incorporated1994
- Employees80.00k
- LocationMcKesson Corp6555 State Highway 161IRVING 75039-2402United StatesUSA
- Phone+1 (972) 446-4800
- Fax+1 (302) 636-5454
- Websitehttp://www.mckesson.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 1.60bn | -42.52m | 15.99bn | 2.85k | -- | 5.20 | 252.16 | 9.98 | -0.2504 | -0.2504 | 8.89 | 17.12 | 0.3464 | 0.606 | 4.07 | 562,590.10 | -0.9191 | -5.98 | -1.07 | -6.84 | 78.88 | 81.28 | -2.65 | -19.56 | 2.53 | -14.59 | 0.2178 | -- | 13.52 | 22.14 | -3.30 | -- | 17.28 | -- |
| Incyte Corporation | 2.16bn | 446.91m | 17.01bn | 1.46k | 38.22 | 6.53 | 33.91 | 7.88 | 2.05 | 2.05 | 9.92 | 12.02 | 0.711 | 10.10 | 7.02 | 1,482,664.00 | 14.72 | 3.65 | 17.41 | 4.37 | 95.70 | 96.02 | 20.70 | 4.76 | 4.81 | -- | 0.0192 | 0.00 | 14.71 | 33.37 | 308.16 | -- | 22.87 | -- |
| Cardinal Health Inc | 149.66bn | -4.21bn | 17.40bn | 49.50k | -- | 17.43 | -- | 0.1162 | -14.24 | -14.24 | 504.32 | 3.42 | 3.67 | 10.64 | 18.46 | 3,023,374.00 | -10.33 | 2.60 | -25.68 | 6.02 | 4.56 | 5.16 | -2.81 | 0.7268 | 0.4796 | 6.92 | 0.8879 | 59.41 | 6.38 | 9.83 | 300.44 | 3.22 | 5.67 | 9.50 |
| AmerisourceBergen Corp. | 182.06bn | 649.35m | 19.43bn | 22.00k | 30.62 | 6.57 | 17.44 | 0.1067 | 3.08 | 3.08 | 861.68 | 14.36 | 4.59 | 15.08 | 13.59 | 8,275,519.00 | 1.64 | 2.11 | 6.81 | 8.73 | 2.75 | 2.78 | 0.3565 | 0.4435 | 0.5638 | 15.64 | 0.576 | 43.62 | 6.94 | 8.48 | -21.75 | 23.77 | 3.24 | 11.22 |
| Seattle Genetics, Inc. | 916.71m | -158.65m | 20.34bn | 1.61k | -- | 10.82 | -- | 22.19 | -0.9701 | -0.9701 | 5.54 | 10.91 | 0.4943 | 0.6316 | 4.80 | 571,160.80 | -8.55 | -14.09 | -9.84 | -16.76 | 95.21 | 90.52 | -17.31 | -27.33 | 4.21 | -- | 0.00 | -- | 40.02 | 26.17 | 28.76 | -- | 32.73 | -- |
| McKesson Corporation | 224.95bn | -980.00m | 29.73bn | 80.00k | -- | 4.82 | 184.66 | 0.1322 | -5.24 | -4.91 | 1,212.64 | 34.88 | 3.69 | 12.54 | 11.91 | 2,811,813.00 | -1.26 | 3.15 | -3.71 | 8.61 | 5.28 | 5.75 | -0.3401 | 0.9135 | 0.5585 | 2.15 | 0.5586 | 15.38 | 2.86 | 9.30 | 93.42 | -- | 6.06 | 10.66 |
| Iqvia Holdings Inc | 11.09bn | 191.00m | 31.88bn | 58.00k | 172.22 | 5.26 | 22.17 | 2.88 | 0.9541 | 0.9541 | 55.54 | 31.22 | 0.4842 | -- | 4.46 | -- | 1.03 | 1.50 | 1.25 | 1.83 | 34.16 | 33.19 | 2.13 | 2.88 | -- | 2.08 | 0.6503 | -- | 6.49 | 15.22 | -14.73 | -11.73 | 47.75 | -- |
| Regeneron Pharmaceuticals Inc | 7.86bn | 2.12bn | 43.96bn | 8.10k | 21.63 | 3.97 | 18.90 | 5.59 | 18.47 | 18.47 | 68.59 | 100.56 | 0.5926 | 0.8517 | 3.20 | 970,790.10 | 15.94 | 17.80 | 18.40 | 20.74 | 90.05 | 92.16 | 26.91 | 25.67 | 3.18 | 77.00 | 0.0605 | 0.00 | 17.18 | 22.77 | -10.97 | 44.30 | 5.23 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2019 | 15.41m | 8.55% |
| BlackRock Fund Advisorsas of 31 Dec 2019 | 9.11m | 5.06% |
| SSgA Funds Management, Inc.as of 31 Dec 2019 | 8.39m | 4.66% |
| Massachusetts Financial Services Co.as of 31 Dec 2019 | 5.50m | 3.05% |
| Boston Partners Global Investors, Inc.as of 31 Dec 2019 | 4.20m | 2.33% |
| Wellington Management Co. LLPas of 31 Dec 2019 | 3.89m | 2.16% |
| Pzena Investment Management LLCas of 31 Dec 2019 | 3.76m | 2.09% |
| Glenview Capital Management LLCas of 31 Dec 2019 | 3.71m | 2.06% |
| Invesco Advisers, Inc.as of 31 Dec 2019 | 3.52m | 1.95% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2019 | 3.07m | 1.71% |
